294 related articles for article (PubMed ID: 16551925)
1. Technologies to shape the future: proteomics applications in anesthesiology and critical care medicine.
Atkins JH; Johansson JS
Anesth Analg; 2006 Apr; 102(4):1207-16. PubMed ID: 16551925
[TBL] [Abstract][Full Text] [Related]
2. [Micro-array based technologies to study the proteome: technological progress and applications].
Mortuaire G; Marchetti P; Formstecher P; Danzé PM
Ann Biol Clin (Paris); 2004; 62(2):139-48. PubMed ID: 15047465
[TBL] [Abstract][Full Text] [Related]
3. Proteomics and the haematologist.
Rees-Unwin KS; Morgan GJ; Davies FE
Clin Lab Haematol; 2004 Apr; 26(2):77-86. PubMed ID: 15053800
[TBL] [Abstract][Full Text] [Related]
4. Approaching clinical proteomics: current state and future fields of application in cellular proteomics.
Apweiler R; Aslanidis C; Deufel T; Gerstner A; Hansen J; Hochstrasser D; Kellner R; Kubicek M; Lottspeich F; Maser E; Mewes HW; Meyer HE; Müllner S; Mutter W; Neumaier M; Nollau P; Nothwang HG; Ponten F; Radbruch A; Reinert K; Rothe G; Stockinger H; Tárnok A; Taussig MJ; Thiel A; Thiery J; Ueffing M; Valet G; Vandekerckhove J; Wagener C; Wagner O; Schmitz G
Cytometry A; 2009 Oct; 75(10):816-32. PubMed ID: 19739086
[TBL] [Abstract][Full Text] [Related]
5. Protein biochips: A new and versatile platform technology for molecular medicine.
Lueking A; Cahill DJ; Müllner S
Drug Discov Today; 2005 Jun; 10(11):789-94. PubMed ID: 15922937
[TBL] [Abstract][Full Text] [Related]
6. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
7. [Present possibilities and future development of clinical proteomics].
Lehmann S; Dupuy A; Peoc'h K; Roche S; Baudin B; Quillard M; Berger F; Briand G; Chwetzoff S; Dine G; Gonzalo P; Dastugue B; Sève M; Siest G; Beaudeux JL
Ann Biol Clin (Paris); 2007; 65(5):463-71. PubMed ID: 17913666
[TBL] [Abstract][Full Text] [Related]
8. Proteomics: recent applications and new technologies.
Elrick MM; Walgren JL; Mitchell MD; Thompson DC
Basic Clin Pharmacol Toxicol; 2006 May; 98(5):432-41. PubMed ID: 16635100
[TBL] [Abstract][Full Text] [Related]
9. Array of informatics: Applications in modern research.
Kozarova A; Petrinac S; Ali A; Hudson JW
J Proteome Res; 2006 May; 5(5):1051-9. PubMed ID: 16674093
[TBL] [Abstract][Full Text] [Related]
10. Array and lab on a chip technology for protein characterization.
Figeys D
Curr Opin Mol Ther; 1999 Dec; 1(6):685-94. PubMed ID: 19629865
[TBL] [Abstract][Full Text] [Related]
11. Technology insight: the application of proteomics in gastrointestinal disease.
Din S; Lennon AM; Arnott ID; Hupp T; Satsangi J
Nat Clin Pract Gastroenterol Hepatol; 2007 Jul; 4(7):372-85. PubMed ID: 17607293
[TBL] [Abstract][Full Text] [Related]
12. An introduction into proteomics and its clinical applications.
Ahram M
Saudi Med J; 2007 Apr; 28(4):499-507. PubMed ID: 17457467
[TBL] [Abstract][Full Text] [Related]
13. Proteomics technology and therapeutics.
Hong ML; Jiang N; Gopinath S; Chew FT
Clin Exp Pharmacol Physiol; 2006; 33(5-6):563-8. PubMed ID: 16700895
[TBL] [Abstract][Full Text] [Related]
14. Proteomics for the identification of new prostate cancer biomarkers.
Ornstein DK; Tyson DR
Urol Oncol; 2006; 24(3):231-6. PubMed ID: 16678055
[TBL] [Abstract][Full Text] [Related]
15. The birth and infancy of proteomic analysis in osteoarthritis research.
De Ceuninck F
Curr Opin Mol Ther; 2007 Jun; 9(3):263-9. PubMed ID: 17608025
[TBL] [Abstract][Full Text] [Related]
16. Casting light on molecular events underlying anti-cancer drug treatment: what can be seen from the proteomics point of view?
Kraljevic S; Sedic M; Scott M; Gehrig P; Schlapbach R; Pavelic K
Cancer Treat Rev; 2006 Dec; 32(8):619-29. PubMed ID: 17069979
[TBL] [Abstract][Full Text] [Related]
17. Proteomics in platelet science.
Perrotta PL; Bahou WF
Curr Hematol Rep; 2004 Nov; 3(6):462-9. PubMed ID: 15496282
[TBL] [Abstract][Full Text] [Related]
18. The future of proteomic analysis in biological systems and molecular medicine.
Bark SJ; Hook V
Mol Biosyst; 2007 Jan; 3(1):14-7. PubMed ID: 17216050
[TBL] [Abstract][Full Text] [Related]
19. Quantitative proteomics for drug toxicity.
Gao Y; Holland RD; Yu LR
Brief Funct Genomic Proteomic; 2009 Mar; 8(2):158-66. PubMed ID: 19351682
[TBL] [Abstract][Full Text] [Related]
20. Plasma proteome analysis: 2D gels and chips.
Herosimczyk A; Dejeans N; Sayd T; Ozgo M; Skrzypczak WF; Mazur A
J Physiol Pharmacol; 2006 Nov; 57 Suppl 7():81-93. PubMed ID: 17228097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
